Brief: Sutro Biopharma Q2 Revenue USD 9.839 Million Vs. IBES Estimate USD 13 Million
12/08/2026 12:01
BRIEF-Sutro Biopharma Q2 Revenue USD 9.839 Million Vs. IBES Estimate USD 13 Million Aug 12 (Reuters) - Sutro Biopharma Q2 operating income USD -29.888 million.
- Q2 net income USD -38.533 million
- Q2 operating expenses USD 39.727 million
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates